A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...

Texas residents who were exposed to greater levels of toxic metals were found to develop markers for type 2 diabetes earlier.

A small new study suggests that time-restricted eating could help improve blood sugar control in some people, thus ...

Recent research has found an association between moderate coffee and caffeine consumption and a lower risk of cardiometabolic ...

Fatty liver disease linked to diabetes and obesity can easily progress to liver cirrhosis, but new research suggests that GLP ...

Metformin is the main first-line drug used to treat type 2 diabetes, but a new study on monkeys suggests it could one day be ...

Tandem Diabetes Care ( TNDM 4.25%) had some encouraging news to report on the regulatory front Thursday, and after it hit the ...

For people with type 1 diabetes, management burden including suboptimal insulin preparations remains a major barrier to ...

A new study has revealed a startling gap in prenatal care, showing that a commonly used screening method for this condition ...

Researchers have discovered that remodeling of extracellular matrix (ECM) in the hypothalamus, specifically around AgRP ...

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.